43North — PathoVax

PathoVax

We make the world’s first low-cost Human Papillomavirus (HPV) vaccine.

We make the world’s first low-cost Human Papillomavirus (HPV) vaccine.

INDUSTRY

Life Sciences

FROM

Baltimore, MD

ABOUT

PathoVax LLC is a vaccine biotechnology startup spun out of Johns Hopkins University in Maryland, focused on developing innovative methods to address unmet needs in cancer management. Their core mission is to develop broad spectrum vaccines against cancer and infectious diseases utilizing a proprietary papillomavirus virus-like particle (VLP) platform.

WATCH

CEO

Joshua Wang

Co-Founder & CEO